发明名称 SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR
摘要 Described herein are an aspirin or active aspirin derivative and a COX-2 inhibitor, at least one of which has an enteric or partial enteric coating, administered in combination yet delivered sequentially, for the treatment and prophylactic treatment of diseases, symptoms and conditions. In some embodiments, the COX-2 inhibitor has the enteric coating; however, the aspirin or active aspirin derivative may additionally or alternately have the enteric coating. In all embodiments, the drug having the enteric coating or enteric formulation is targeted for absorption in the small intestine or colon, or both the small intestine and the colon.
申请公布号 US2015164818(A1) 申请公布日期 2015.06.18
申请号 US201414571781 申请日期 2014.12.16
申请人 Van Patten Peter 发明人 Van Patten Peter
分类号 A61K9/50;A61K45/06;A61K9/00;A61K31/616;A61K31/60 主分类号 A61K9/50
代理机构 代理人
主权项 1. A method of sequentially administering an aspirin or active aspirin derivative and a COX-2 inhibitor for partitioned absorption, at least one of which has an enteric or partial enteric coating for bioabsorption in a patient's small intestine or colon.
地址 Aurora MN US